Indication

Hemophilia A

Hemophilia A is an inherited bleeding disorder caused by a congenital deficiency or functional defect of coagulation factor VIII, an essential cofactor in the intrinsic clotting cascade. Read more about Hemophilia A

77 drugs 39 manufacturers

Advertisement

Drugs that treat it

Common Hemophilia A therapies.

Showing 37–45 of 77 drugs

Filter & compare in the drug finder →Opens the drug finder with Hemophilia A preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hemophilia A.

Hemophilia A is an inherited bleeding disorder caused by a congenital deficiency or functional defect of coagulation factor VIII, an essential cofactor in the intrinsic clotting cascade.

Transmitted as an X-linked recessive trait, it predominantly affects males, while females are typically asymptomatic or mildly symptomatic carriers.

The condition impairs secondary hemostasis, predisposing patients to prolonged or excessive hemorrhage following trauma or invasive procedures.

Depending on baseline plasma factor VIII activity, clinical manifestations range from excessive post-surgical bleeding in mild disease to recurrent spontaneous hemorrhages—most characteristically painful hemarthroses and deep muscle hematomas that can lead to chronic arthropathy—in severe cases.

Personalize your experience

Follow Hemophilia A and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it